Nevanac and Oxycodone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nevanac (nepafenac) and Oxycodone (oxycodone hydrochloride). Common drug interactions include disturbance in attention among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Nevanac and Oxycodone. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Nevanac?

Nevanac has active ingredients of nepafenac. It is often used in cataract removal. eHealthMe is studying from 1,755 Nevanac users. Check the latest studies of Nevanac.

What is Oxycodone?

Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.

On Aug, 09, 2026

29 people who take Nevanac and Oxycodone together, and have interactions are studied.

Nevanac and Oxycodone drug interactions.

What are the common drug interactions of Nevanac and Oxycodone, by gender? *:

female:

Disturbance in attention
Gait disturbance
Memory impairment
Abnormal behaviour
Lactic acidosis (low ph in body tissues)
Activities of daily living impaired
Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
Chronic kidney disease
Neuropathy peripheral (surface nerve damage)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)

male:

Chronic kidney disease
Renal failure (kidney dysfunction)
Hypertension (high blood pressure)
Oedema peripheral (superficial swelling)
Stress
Cardiac failure
Cerebral haemorrhage (bleeding within the brain)
Lymphadenopathy (disease or enlargement of lymph nodes)
Metastases to lymph nodes (cancer spreads to lymph node)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)

What are the common drug interactions of Nevanac and Oxycodone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)

40-49:

n/a

50-59:

Chronic kidney disease

60+:

Disturbance in attention
Gait disturbance
Erythema (redness of the skin)
Hepatic neoplasm malignant (liver cancer)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Oedema peripheral (superficial swelling)
Stress
Neuropathy peripheral (surface nerve damage)
Anaemia (lack of blood)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 27.59%
Type 2 Diabetes: 7 people, 24.14%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 6 people, 20.69%
Constipation: 6 people, 20.69%
Inflammation: 5 people, 17.24%
High Blood Cholesterol: 5 people, 17.24%
High Blood Pressure: 5 people, 17.24%
Infection: 5 people, 17.24%
Fungal Infection: 4 people, 13.79%
Itching: 4 people, 13.79%

* Approximation only. Some reports may have incomplete information.

Do you take Nevanac and Oxycodone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously